However, the model should only be used for further evaluation of lead candidate therapeutics or prophylactics which have demonstrated highly significant anti-cryptosporidial activity in vitro and in at least one less sentient species rodent model such as neonatal mice.
← all excerpts
Calf Clinical Model of Cryptosporidiosis for Efficacy Evaluation of Therapeutics.
1
—
—